Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
|Articles|December 2, 2014
- Pharmaceutical Technology-12-02-2014
- Volume 38
- Issue 12
VIDEOJET Thermal Ink Printer Offers Increased Resolution
VIDEOJET’s thermal ink jet printer, the Videojet 8610, is designed for high-resolution coding with MEK-based fluids on non-porous packaging, including films, foils, plastics, and coated stocks.
VIDEOJET’s thermal ink jet printer, the Videojet 8610, is designed for high-resolution coding with MEK-based fluids on non-porous packaging, including films, foils, plastics, and coated stocks.
The printer features three components: a controller with user interface, an industrial printhead featuring a Cartridge Readiness System, and a disposable ink-jet cartridge. It has wear-resistant parts and no calibration or tuning requirements.
Each cartridge change provides a new print array. Code Assurance assists operators in getting the correct code on the product, the company reports.
VIDEOJET
Articles in this issue
almost 12 years ago
Sartorius Bioreactor and Microbial Fermenter Increases Efficiencyalmost 12 years ago
Ross Planetary Mixers Increase Mixing Optionsalmost 12 years ago
The Bio/Pharma Working Lifealmost 12 years ago
FDA Realigns Drug Inspection and Manufacturing Oversightalmost 12 years ago
Fitzpatrick Roll Compaction Series Improves Accuracyalmost 12 years ago
Drug Scandals Impact Industry in Japanalmost 12 years ago
Securing the Single-Use Supply Chainalmost 12 years ago
Improving Job Market Creates Opportunity for Changealmost 12 years ago
FDA Approves Novel Treatments in 2014almost 12 years ago
Novel Technologies Win CPhI Pharma AwardsRelated to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Trending on Pharmaceutical Technology
1
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
2
Risk-Based Life Cycle Management of Master Production and Control Records to Strengthen Data Integrity and GMP Inspection Readiness Part 2: Practical Considerations for CGMP Documentation Systems
3
PharmTech AI Pulse Check: Validating Multi-Agent Systems, OCR Models in GxP
4
CPHI Milan: USP Benchmarks Reshape Procurement Incentives
5